28 November – 04 December 2016
First new HIV vaccine efficacy study
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. Find source
Weaponized antibodies use new tricks to fight cancer
After decades of frustration, efforts to develop antibodies that can ferry drugs into cancer cells and minimize damage to healthy tissue are gathering steam. The next generation of ‘weaponized antibody’ therapies, called antibody–drug conjugates (ADCs), is working its way through clinical trials. Find source
UK moves closer to allowing ‘three-parent’ babies
The United Kingdom may soon become the first country to explicitly permit the birth of children from embryos modified to contain three people’s DNA. Find source
Thunderstorm asthma: 8 dead in Australia from freak illness
A freak illness known as thunderstorm asthma has now killed at least eight people in Australia.Thousands were hospitalized in Melbourne and other parts of Victoria last Monday with breathing problems due to a rare combination of weather and pollen. Find source
Experimental treatments aim to prevent brain damage in babies
As many as 800,000 babies die each year when blood and oxygen stop flowing to the brain around the time of birth. Neuroscientists and physicians have embarked on what they hope will be a revolution in treatments to prevent brain damage in newborn babies. Find source
